The protein expression and modifications of FoxO1 could be greatly altered under a variety of disease conditions including infection, ischemic reperfusion injury (IRI), allergic asthma, obesity and tumorigenesis (Table 1). This evidence concerns the gene FOXO1 and obesity due to melanocortin 4 receptor deficiency.